Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 87,630 | 103,147 | 51,352 | 86,522 | 51,089 |
| Receivables | 158,429 | 49,999 | 27,421 | 15,505 | 28,577 |
| Inventories | 206,465 | 170,235 | 172,906 | 163,280 | 124,724 |
| Other current assets | 6,530 | 0 | 0 | 0 | 0 |
| TOTAL | $466,512 | $331,410 | $257,013 | $270,402 | $208,729 |
| Non-Current Assets | |||||
| PPE Net | 65,057 | 54,707 | 53,835 | 58,261 | 50,935 |
| Intangibles | 4,162 | 3,990 | 4,029 | 4,543 | 5,258 |
| Other Non-Current Assets | 88,511 | 98,571 | 14,305 | 15,255 | 11,330 |
| TOTAL | $157,730 | $157,268 | $72,169 | $78,059 | $67,523 |
| Total Assets | $624,242 | $488,678 | $329,182 | $348,461 | $276,253 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 22,519 | 20,219 | 15,660 | 13,229 | 12,429 |
| Accrued Expenses | 40,466 | 34,105 | 32,919 | 24,990 | 17,215 |
| Other current liabilities | 2,647 | N/A | N/A | N/A | N/A |
| TOTAL | $69,541 | $55,542 | $49,806 | $39,267 | $30,378 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69,330 | 72,337 | 130,594 | 142,833 | 94,866 |
| Deferred Revenues | N/A | N/A | 182 | 143 | 143 |
| Other Non-Current Liabilities | 0 | 1,673 | 2,107 | 1,850 | 397 |
| TOTAL | $77,381 | $84,118 | $144,170 | $157,220 | $104,702 |
| Total Liabilities | $146,922 | $139,660 | $193,976 | $196,487 | $135,080 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 238,159 | 237,615 | 228,220 | 222,156 | 195,920 |
| Common Shares | 24 | 24 | 23 | 22 | 20 |
| Retained earnings | -161,653 | -308,583 | -506,256 | -478,017 | -412,113 |
| Other shareholders' equity | -90 | 0 | 0 | 0 | 0 |
| TOTAL | $477,320 | $349,018 | $135,206 | $151,974 | $141,173 |
| Total Liabilities And Equity | $624,242 | $488,678 | $329,182 | $348,461 | $276,253 |